Drug: |
KQB198 + Imatinib |
|||
|---|---|---|---|---|
Trial: |
KQB198 in Combination With Imatinib in Participants With Advanced/​Metastatic GIST in 1st Line Setting |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
USC-Norris Cancer Center1520 San Pablo St. |
Principal Investigator: |
Mark Agulnik, MD |
|---|---|
Contact: |
Daisy Sosa 323-865-0089 Daisy.Sosa@med.usc.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
USC-Norris Cancer Center Website: |
http://uscnorriscancer.usc.edu/cltrials/ |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.